Abstracts tagged "juvenile dermatomyositis and outcome measures"

Abstract Number: 1370 • 2016 ACR/ARHP Annual Meeting
Development and Validation of a Composite Disease Activity Score for Juvenile Dermatomyositis
Silvia Rosina¹, Alessandro Consolaro¹, Pieter van Dijkhuizen¹, Kiran Nistala², Nicola Ruperto¹, Clarissa Pilkington³ and Angelo Ravelli¹, ¹Rheumatology, Giannina Gaslini Institute, Genova, Italy, ²Centre for Rheumatology, University College London, London, United Kingdom, ³Paediatric Rheumatology, Great Ormond Street Hospital NHS Trust, London, United Kingdom
Background/Purpose: JDM is a multisystem vasculopathic disease that primarily affects the skin and muscles. Most tools for assessment of disease activity in JDM are lenghty,…
Abstract Number: 1373 • 2016 ACR/ARHP Annual Meeting
Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologists
Janice Tiao^1,2, Rui Feng³, Emily M. Berger⁴, John F. Brandsema⁵, Carrie C. Coughlin⁶, Neelam Khan², Elizabeth A. Kichula⁵, Melissa A. Lerman⁷, Svetlana Lvovich⁸, Patrick J. McMahon⁹, Lisa G. Rider¹⁰, Adam I. Rubin², Lisabeth V. Scalzi¹¹, Douglas M. Smith⁵, Alysha J. Taxter¹², James R. Treat⁹, Ryan P. Williams¹³, Sabrina W. Yum⁵, Joyce Okawa² and Victoria P. Werth^1,2, ¹Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, ²Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ³Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, ⁴Hackensack University Medical Center, Hackensack, NJ, ⁵Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁶Division of Dermatology, Washington University School of Medicine, St. Louis, MO, ⁷Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁸St. Christopher's Hospital for Children, Philadelphia, PA, ⁹Division of Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA, ¹⁰Environmental Autoimmunity Group, Program of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, ¹¹Department of Rheumatology, Penn State Hershey Children’s Hospital, Hershey, PA, ¹²Pediatrics, Brenner Children's Hospital, Wake Forest Baptist Medical Center, Winston-Salem, NC, ¹³Minneapolis Clinic of Neurology, Maple Grove, MN
Background/Purpose: The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool-Binary Method (CAT-BM) have been shown to be reliable and valid outcome…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].